Biosimilars 101: Facts, Risks & Opportunities

December 20, 2016

The emergence of biosimilars over the last few years has introduced a new competitive specialty pharmaceuticals market to combat the rising price tags on expensive biologics.

Previous Article
Building the Ideal Construction Project Team
Building the Ideal Construction Project Team

The list of possible challenges that could arise during the life cycle of a medical construction project ar...

Next Article
The Post-Acute Care Conundrum
The Post-Acute Care Conundrum

With healthcare’s movement to value-based payment requiring cross-continuum patient engagement, health syst...

×

Like what you see? Get fresh content by subscribing to our blog.

Thank you! We post 1-2 times per week.
Error - something went wrong!